Mark Coles
Co-founder @Mestag Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Co-founder @Mestag Therapeutics
London, GB
Mestag Therapeutics is a fast-moving, stealth mode biotech, newly formed to explore emerging understanding of fibroblast subpopulations as targetable drivers of disease. Our goal is to bring transformative therapies to enriched patient populations with enduring unmet needs in inflammatory disease and oncology. Mestag Therapeutics’ founders are world leaders in fibroblast biology and severe diseases. We are actively assembling a driven, motivated team to explore new therapeutic opportunities. Backed by SV Health Investors, a leading life sciences & healthcare investor with over $3 billion in capital commitments, Mestag has raised capital from the Impact Medicine Fund, which invests in precision medicine therapeutics in areas of high unmet need.
EDUCATION
University of California, Berkeley
Doctor of Philosophy (Ph.D.), Molecular Cell Biology
Cornell University
Bachelor’s Degree, Microbiology, General
SKILLS
ABOUT MARK COLES
Research in the Stromal and Systems Immunology Group at the Kennedy Institute of…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.